We are live on ! Find out more
CVS icon

CVS Health

1,972 hedge funds and large institutions have $68.1B invested in CVS Health in 2020 Q4 according to their latest regulatory filings, with 277 funds opening new positions, 842 increasing their positions, 720 reducing their positions, and 94 closing their positions.

New
Increased
Maintained
Reduced
Closed

195% more first-time investments, than exits

New positions opened: 277 | Existing positions closed: 94

38% more call options, than puts

Call options by funds: $1.88B | Put options by funds: $1.36B

30% more funds holding in top 10

Funds holding in top 10: 4660 (+14)

17% more capital invested

Capital invested by funds: $58.2B → $68.1B (+$9.97B)

17% more repeat investments, than reductions

Existing positions increased: 842 | Existing positions reduced: 720

9% more funds holding

Funds holding: 1,8151,972 (+157)

0.1% less ownership

Funds ownership: 76.22%76.12% (-0.1%)

Holders
1,972
Holders Change
+157
Holders Change %
+8.65%
% of All Funds
34.9%
Holding in Top 10
60
Holding in Top 10 Change
+14
Holding in Top 10 Change %
+30.43%
% of All Funds
1.06%
New
277
Increased
842
Reduced
720
Closed
94
Calls
$1.88B
Puts
$1.36B
Net Calls
+$523M
Net Calls Change
-$123M
Name Holding Trade Value Shares
Change
Change in
Stake
BFEC
551
Benjamin F. Edwards & Company
Missouri
$5.36M +$845K +12,988 +20%
MLM
552
Mount Lucas Management
Pennsylvania
$5.34M +$58.5K +900 +1%
WB
553
Webster Bank
Connecticut
$5.26M -$757K -11,642 -13%
MFG
554
Monte Financial Group
Connecticut
$5.24M -$83.5K -1,284 -2%
BWM
555
Buckley Wealth Management
Nevada
$5.19M +$452K +6,946 +10%
BIM
556
Bridgecreek Investment Management
Oklahoma
$5.13M -$145K -2,225 -3%
RAM
557
Riggs Asset Management
Pennsylvania
$5.13M -$3.76M -57,754 -43%
LCM
558
Laurion Capital Management
New York
$5.07M +$1.51M +23,178 +45%
VCM
559
Vision Capital Management
Oregon
$5.07M +$1.32M +20,263 +38%
AB
560
Amalgamated Bank
New York
$5.06M -$11.8K -182 -0.2%
B
561
Bailard
California
$5.06M -$9.69K -149 -0.2%
ATC
562
Argent Trust Co
Tennessee
$5.04M +$316K +4,865 +7%
KCM
563
Kanawha Capital Management
Virginia
$5M +$42.3K +650 +0.9%
SWM
564
Stockman Wealth Management
Montana
$4.99M +$1.16M +17,876 +32%
LCC
565
Lincoln Capital Corp
Rhode Island
$4.99M -$207K -3,187 -4%
SCP
566
Shorepoint Capital Partners
Massachusetts
$4.98M +$169K +2,604 +4%
TCBWMS
567
Texas Capital Bank Wealth Management Services
Texas
$4.97M +$1.01M +15,513 +27%
RWM
568
Rench Wealth Management
Texas
$4.93M +$189K +2,903 +4%
BCM
569
BTC Capital Management
Iowa
$4.92M -$4.01M -61,710 -46%
NMIMC
570
Northwestern Mutual Investment Management Company
Wisconsin
$4.91M +$1.69K +26 +0%
BBVA
571
Banco Bilbao Vizcaya Argentaria
Spain
$4.9M -$1.6M -24,593 -26%
BIMC
572
Benson Investment Management Company
Virginia
$4.9M +$26.9K +414 +0.6%
CP
573
Corbenic Partners
Pennsylvania
$4.89M -$618K -9,507 -12%
RIM
574
Regent Investment Management
Kentucky
$4.88M -$170K -2,620 -4%
APA
575
Allegiant Private Advisors
Florida
$4.86M +$4.63M +71,154 New

CVS Hedge Fund Activity: Q4 2020 in Review

1,972 of the 5,651 institutional investors tracked by Wall St. Rank reported a position in CVS Health (CVS) for Q4 2020, worth a combined $68.1B — up 17% from $58.2B a quarter earlier.

Buyers outnumbered sellers: 277 funds opened new CVS positions and 94 closed out — a net gain of 183 holders — while 842 added to existing stakes and 720 trimmed.

The largest buyer was Capital International Investors, adding an estimated $272M. The largest seller was BlackRock, cutting an estimated $508M.

  • 1,972 institutional investors held CVS Health (CVS) as of Q4 2020, up from 1,815 in Q3 2020.
  • Funds reported $68.1B of CVS Health stock for Q4 2020, up 17% quarter-over-quarter.
  • 277 funds opened new CVS Health positions in Q4 2020 and 94 closed out, a net change of +183 holders.
  • The largest CVS Health buyer in Q4 2020 was Capital International Investors, an estimated $272M added.
  • The largest CVS Health seller in Q4 2020 was BlackRock, an estimated $508M sold.

Based on aggregated 13F filings for Q4 2020.